Phenanthraquinone inhibits eNOS activity and suppresses vasorelaxation

Department of Environmental Medicine, Institute of Community Medicine, Master's Program in Environmental Sciences, Graduate School Doctoral Program in Medical Sciences, Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2001-07, Vol.281 (1), p.25-R30
Hauptverfasser: Kumagai, Yoshito, Hayashi, Toshio, Miyauchi, Takashi, Endo, Akiko, Iguchi, Akihisa, Kiriya-Sakai, Minako, Sakai, Satoshi, Yuki, Koichi, Kikushima, Makoto, Shimojo, Nobuhiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Department of Environmental Medicine, Institute of Community Medicine, Master's Program in Environmental Sciences, Graduate School Doctoral Program in Medical Sciences, Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575; and Department of Geriatrics, Nagoya University School of Medicine, Showa-ku, Nagoya 466, Japan Diesel exhaust particles cause an impairment of endothelium-dependent vasorelaxation and are associated with cardiopulmonary-related diseases and mortality, but the mechanistic details are poorly understood. Since we reported previously that phenanthraquinone, an environmental chemical contained in diesel exhaust particles, suppresses neuronal nitric oxide synthase (nNOS) activity by shunting electrons away from the normal catalytic pathway, it was hypothesized that phenanthraquinone inhibits endothelial NOS (eNOS) activity and affects vascular tone. Therefore, the effects of phenanthraquinone on eNOS activity, endothelium-dependent relaxation, and blood pressure were examined in the present study. Phenanthraquinone inhibited NO formation evaluated by citrulline formed by total membrane fraction of bovine aortic endothelial cells with an IC 50 value of 0.6 µM. A kinetic study revealed that phenanthraquinone is a competitive inhibitor with respect to NADPH and a noncompetitive inhibitor with respect to L -arginine. Endothelium-dependent relaxation of rat aortic rings by ACh was significantly inhibited by phenanthraquinone (5 µM), whereas the endothelium-independent relaxation by nitroglycerin was not. Furthermore, an intraperitoneal injection of phenanthraquinone (0.36 mmol/kg) to rats resulted in an elevation of blood pressure (1.4-fold, P  
ISSN:0363-6119
1522-1490
DOI:10.1152/ajpregu.2001.281.1.r25